It has been previously shown that both PI3K and MAPK pathways are activated by IGF-1 to promote cell survival, but to our knowledge, it has never been shown that IGF-1 activates MMPs in a breast cancer cell line and that this, in part, functions via the PI3K and MAPK pathways. The gene discussed is IGF1; the disease is breast carcinoma.